Three clinical trials have examined the efficacy and safety of single dose azithromycin (30 mg/kg) in children with uncomplicated acute otitis media (AOM). In the first trial, a small pilot study, the ...
Background Azithromycin mass drug administration (MDA) to ages 1–59 months can reduce childhood mortality; however, more ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback